Market research
000623.SHE Jilin Aodong Pharmaceutical Group Co., Ltd
SHE CNY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 21B
- P/E ratio
- 6.54
- Analyst target
- 37.44
- Dividend yield
- 2.8%
- Beta
- 0.5
Profile
Company facts
- Exchange
- SHE
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CNE000000719
- Market cap
- 21B
- P/E ratio
- 6.54
- Analyst target
- 37.44
- Dividend yield
- 2.8%
- Beta
- 0.5
About
About Jilin Aodong Pharmaceutical Group Co., Ltd
Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China. It provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, retail, and distribution of medicines; production and sale of packaging materials; and information consulting and advertising design and production activities. In addition, the company offers pharmaceutical excipients and packaging materials; produces and sells enzyme stock solutions; ginseng and antler products; sells health care products; and processes edible agricultural products, etc. Jilin Aodong Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Dunhua, China.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 000623.SHE discussion.
5 years, 5 months ago
Jilin Aodong Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 5.1% below its 200 day moving average.
From a valuation standpoint, the stock is 14.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.
Jilin Aodong Pharmaceutical Group Co., Ltd's total revenue sank by 30.9% to $495M since the same quarter in the previous year.
Its net income has increased by 68.1% to $484M since the same quarter in the previous year.
Finally, its free cash flow fell by 313.2% to $-61M since the same quarter in the previous year.
Based on the above factors, Jilin Aodong Pharmaceutical Group Co., Ltd gets an overall score of 2/5.